Auvi-q and Synthroid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Auvi-q (epinephrine) and Synthroid (levothyroxine sodium). Common drug interactions include tachycardia among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Auvi-q and Synthroid. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Auvi-q?

Auvi-q has active ingredients of epinephrine. eHealthMe is studying from 878 Auvi-q users. Check the latest studies of Auvi-q.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,198 Synthroid users. Check the latest studies of Synthroid.



On Jul, 16, 2026

34 people who take Auvi-q and Synthroid together, and have interactions are studied.

Auvi-q and Synthroid drug interactions.

What are the common drug interactions of Auvi-Q and Synthroid, by gender? *:

female:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Abdominal pain
  4. Adverse drug reaction
  5. Anger
  6. Bell's palsy (facial paralysis)
  7. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  8. Bruxism (habitual grinding of the teeth, typically during sleep)
  9. Chest discomfort
  10. Concussion (short loss of normal brain function in response to a head injury)

male:

  1. Abdominal distension
  2. Abdominal pain
  3. Constipation
  4. Dehydration (dryness resulting from the removal of water)
  5. Depression
  6. Device dislocation
  7. Diarrhoea
  8. Diplopia (double vision)
  9. Dizziness
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

What are the common drug interactions of Auvi-Q and Synthroid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Drug ineffective
  3. Oral herpes (viral infection of mouth)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anxiety
  6. Chills (felling of cold)
  7. Dizziness
  8. Ear discomfort
  9. Eye irritation
  10. Fatigue (feeling of tiredness)

50-59:

  1. Adverse drug reaction
  2. Bell's palsy (facial paralysis)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Bruxism (habitual grinding of the teeth, typically during sleep)
  5. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Endocarditis (inflammation in heart muscle)
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

60+:

  1. Breast cancer stage i
  2. Abdominal pain
  3. Diarrhoea
  4. Drug effect decreased
  5. Emotional distress
  6. Infection
  7. Irritable bowel syndrome
  8. Secretion discharge

What are the existing conditions these people have? *

  1. Asthma: 10 people, 29.41%
  2. Immunodeficiency Common Variable: 8 people, 23.53%
  3. Dehydration (dryness resulting from the removal of water): 6 people, 17.65%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 14.71%
  5. Nasal Polyps (masses that develop in the lining of the nose): 4 people, 11.76%
  6. Drowsiness: 4 people, 11.76%
  7. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 3 people, 8.82%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 8.82%
  9. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 8.82%
  10. Hypersensitivity: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Auvi-q and Synthroid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Auvi-q and Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Auvi-q:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Auvi-q and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synthroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on epinephrine and levothyroxine sodium (the active ingredients of Auvi-q and Synthroid, respectively), and Auvi-q and Synthroid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: